Package 62135-766-01

Brand: clindamycin hydrochloride

Generic: clindamycin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 62135-766-01
Digits Only 6213576601
Product NDC 62135-766
Description

100 CAPSULE in 1 BOTTLE (62135-766-01)

Marketing

Marketing Status
Marketed Since 2024-01-12
Brand clindamycin hydrochloride
Generic clindamycin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0f266520-6156-ae80-e063-6394a90a8dc6", "openfda": {"upc": ["0362135766016", "0362135764012", "0362135765019"], "unii": ["T20OQ1YN1W"], "rxcui": ["197518", "284215", "309329"], "spl_set_id": ["e8167412-882e-4143-93c6-49e68adbcf16"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (62135-766-01)", "package_ndc": "62135-766-01", "marketing_start_date": "20240112"}], "brand_name": "Clindamycin Hydrochloride", "product_id": "62135-766_0f266520-6156-ae80-e063-6394a90a8dc6", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "62135-766", "generic_name": "Clindamycin Hydrochloride", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin Hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA065243", "marketing_category": "ANDA", "marketing_start_date": "20050812", "listing_expiration_date": "20261231"}